Waters raised to Outperform at Wolfe on BD Life Sciences deal
Seeking Alpha News (Wed, 10-Dec 11:29 AM ET)
Jefferies Remains a Buy on Becton Dickinson (BDX)
TipRanks (Wed, 10-Dec 8:46 AM ET)
PRNewswire (Thu, 4-Dec 6:50 AM ET)
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
PRNewswire (Wed, 3-Dec 6:50 AM ET)
PRNewswire (Mon, 24-Nov 6:50 AM ET)
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
PRNewswire (Mon, 17-Nov 4:30 PM ET)
BD Onclarity HPV Assay for BD COR and BD Viper LT Systems Receive WHO Prequalification
PRNewswire (Mon, 17-Nov 6:50 AM ET)
PRNewswire (Thu, 13-Nov 6:50 AM ET)
PRNewswire (Wed, 12-Nov 6:50 AM ET)
BD Delivers Margin Expansion and Sets 2026 Growth Targets Amid Strong Medical Segment Momentum
Market Chameleon (Thu, 6-Nov 3:02 AM ET)
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.
As of December 11, 2025, BDX stock price climbed to $200.43 with 1,511,975 million shares trading.
BDX has a beta of 0.44, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.06 to the broad based SPY ETF.
BDX has a market cap of $57.21 billion. This is considered a Large Cap stock.
Last quarter Becton Dickinson And Company reported $6 billion in Revenue and $3.96 earnings per share. This fell short of revenue expectation by $-17 million and exceeded earnings estimates by $.05.
In the last 3 years, BDX traded as high as $287.32 and as low as $162.29.
The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, SPY, IVV, VO.
BDX has underperformed the market in the last year with a return of -7.6%, while SPY returned +15.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BDX shares. However, BDX has outperformed the market in the last 3 month and 2 week periods, returning +6.9% and +3.9%, while SPY returned +5.9% and +1.4%, respectively. This indicates BDX has been having a stronger performance recently.
BDX support price is $195.53 and resistance is $201.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX shares will trade within this expected range on the day.
